BACKGROUND: Community-acquired pneumonia (CAP) is the most frequent infection-related cause of death. The reference standard to diagnose CAP is a new infiltrate on chest radiograph in the presence of recently acquired respiratory signs and symptoms. This study aims to evaluate the diagnostic and prognostic accuracy of clinical signs and symptoms and laboratory biomarkers for CAP. METHODS: 545 patients with suspected lower respiratory tract infection, admitted to the emergency department of a university hospital were included in a pre-planned post-hoc analysis of two controlled intervention trials. Baseline assessment included history, clinical examination, radiography and measurements of procalcitonin (PCT), highly sensitive C-reactive prot...
Lower respiratory tract infection is the most common cause of acute exacerbations of chronic obstruc...
Background Biomarkers may facilitate clinical decisions in order to guide antimicrobial treatment an...
Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality. Biomar...
Abstract Background Community-acquired pneumonia (CAP) is the most frequent infection-related cause ...
ESCAPED Study GroupInternational audienceIntroductionCommunity-acquired pneumonia (CAP) requires pro...
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reacti...
Community-acquired pneumonia (CAP) is a dangerous disease caused by a spectrum of bacterial and vira...
Community-acquired pneumonia (CAP) is defined as an infection of the alveolar or gas-exchanging port...
Community-acquired pneumonia (CAP) is defined as an infection of the alveolar or gas-exchanging port...
OBJECTIVES: To quantify the diagnostic accuracy of selected inflammatory markers in addition to symp...
Community-acquired pneumonia (CAP) is a dangerous disease caused by a spectrum of bacterial and vira...
Current diagnostics for community-acquired pneumonia (CAP) include testing for a wide range of patho...
OBJECTIVES: To quantify the diagnostic accuracy of selected inflammatory markers in addition to symp...
Background: Biological markers such as procalcitonin, may be helpful for the diagnosis of HAP. Proca...
INTRODUCTION: Measurement of prohormones representing different pathophysiological pathways could en...
Lower respiratory tract infection is the most common cause of acute exacerbations of chronic obstruc...
Background Biomarkers may facilitate clinical decisions in order to guide antimicrobial treatment an...
Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality. Biomar...
Abstract Background Community-acquired pneumonia (CAP) is the most frequent infection-related cause ...
ESCAPED Study GroupInternational audienceIntroductionCommunity-acquired pneumonia (CAP) requires pro...
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reacti...
Community-acquired pneumonia (CAP) is a dangerous disease caused by a spectrum of bacterial and vira...
Community-acquired pneumonia (CAP) is defined as an infection of the alveolar or gas-exchanging port...
Community-acquired pneumonia (CAP) is defined as an infection of the alveolar or gas-exchanging port...
OBJECTIVES: To quantify the diagnostic accuracy of selected inflammatory markers in addition to symp...
Community-acquired pneumonia (CAP) is a dangerous disease caused by a spectrum of bacterial and vira...
Current diagnostics for community-acquired pneumonia (CAP) include testing for a wide range of patho...
OBJECTIVES: To quantify the diagnostic accuracy of selected inflammatory markers in addition to symp...
Background: Biological markers such as procalcitonin, may be helpful for the diagnosis of HAP. Proca...
INTRODUCTION: Measurement of prohormones representing different pathophysiological pathways could en...
Lower respiratory tract infection is the most common cause of acute exacerbations of chronic obstruc...
Background Biomarkers may facilitate clinical decisions in order to guide antimicrobial treatment an...
Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality. Biomar...